Search alternatives:
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
n decrease » nn decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
50 n » 50 ns (Expand Search), 50 ng (Expand Search), 50 _ (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
n decrease » nn decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
50 n » 50 ns (Expand Search), 50 ng (Expand Search), 50 _ (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
nLTD decreases the molecular proximity between endogenous spine cofilin and F-actin
Published 2014“…Data are expressed as mean ± SEM of the “% FRET” values determined using the Zeiss LSM 510 software module for FRET acceptor photobleaching (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0094787#s2" target="_blank">Methods</a>); *p<0.05, **p<0.01 compared to control alone; <sup>#</sup>p<0.05 compared to nLTD alone; <sup>XX</sup>p<0.01 compared to CIN alone, two-way ANOVA, followed by Bonferroni post hoc test., (number of spines: ctrl = 43, nLTD = 29, CIN = 49, CIN+nLTD = 77). …”
-
10
-
11
-
12
Proteasome activity was decreased in the <i>myc-rpt6-S119A</i> mutant.
Published 2017“…<p>(A) Lysates from strains in stationary phase (A<sub>600</sub>>5.0) were subjected to native gel electrophoresis followed by an in-gel activity assay with the fluorogenic proteasome substrate Suc-LLVY-AMC. …”
-
13
-
14
Viability of microencapsulated FP ICCs decreased with time post-transplantation.
Published 2013“…<p>A) Fluorescent images of encapsulated FP ICCs stained with 6-CFDA for viable cells (green) and PI for non-viable cells (red) to assess viability at (A) pre-transplantation, (B) day 1, (C) day 3, (D) day 7, (E) day 14 and (F) day 21 post-transplantation. B) Viability decreased with time post-transplantation. Values are mean ± SEM (n = 100 microcapsules/mice for each time point); *p<0.05 viability for days 7 to 21 when compared to pre-transplantation control and days 1 and 3 post-transplantation; #p<0.05 viability for days 14 and 21 when compared to day 7 post-transplantation (one-way ANOVA with post-hoc Tukey-Kramer Multiple-Comparison test).…”
-
15
-
16
-
17
-
18
-
19
-
20